Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech
Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech
IndiaTimes
0 shares
1 views
- More about:
Covaxin- Bharat Biotech
You might like
Related news coverage
Bharat Biotech denies wrongdoing in $324mn COVAXIN deal with Brazil
MENAFN.com
(MENAFN - NewsBytes) Hyderabad-based pharmaceutical company Bharat Biotech denied any wrongdoing on its part after Brazil suspended..
-
When can your kid return to school? AIIMS chief answers
MENAFN.com
-
Covid-19: WHO accepts expression of interest for Covaxin emergency use listing
IndiaTimes
-
WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listing
IndiaTimes
-
Bharat Biotech, WHO pre-submission meeting on June 23: WHO
IndiaTimes
Advertisement
More coverage
Vir Das, Konkona raise concern after Covaxin was denied approval in the US
Mid-Day
The US Food and Drug Administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech,..
-
No emergency use, US FDA asks Bharat Biotech to obtain full approval
Indian Express
-
Ocugen to seek emergency nod for Covaxin from Health Canada
IndiaTimes
-
Ocugen to seek full approval for Covaxin in US via BLA instead of EUA
IndiaTimes
-
Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada
IndiaTimes